Entry |
|
Symbol |
HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras
|
Name |
(RefSeq) HRas proto-oncogene, GTPase
|
KO |
|
Organism |
|
Pathway |
hsa01521 | EGFR tyrosine kinase inhibitor resistance |
hsa04072 | Phospholipase D signaling pathway |
hsa04213 | Longevity regulating pathway - multiple species |
hsa04550 | Signaling pathways regulating pluripotency of stem cells |
hsa04625 | C-type lectin receptor signaling pathway |
hsa04650 | Natural killer cell mediated cytotoxicity |
hsa04660 | T cell receptor signaling pathway |
hsa04662 | B cell receptor signaling pathway |
hsa04664 | Fc epsilon RI signaling pathway |
hsa04810 | Regulation of actin cytoskeleton |
hsa04919 | Thyroid hormone signaling pathway |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications |
hsa04935 | Growth hormone synthesis, secretion and action |
hsa05022 | Pathways of neurodegeneration - multiple diseases |
hsa05163 | Human cytomegalovirus infection |
hsa05166 | Human T-cell leukemia virus 1 infection |
hsa05167 | Kaposi sarcoma-associated herpesvirus infection |
hsa05170 | Human immunodeficiency virus 1 infection |
hsa05207 | Chemical carcinogenesis - receptor activation |
hsa05208 | Chemical carcinogenesis - reactive oxygen species |
hsa05230 | Central carbon metabolism in cancer |
hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Network |
|
Element |
N00001 | EGF-EGFR-RAS-ERK signaling pathway |
N00002 | BCR-ABL fusion kinase to RAS-ERK signaling pathway |
N00003 | Mutation-activated KIT to RAS-ERK signaling pathway |
N00004 | Duplication or mutation-activated FLT3 to RAS-ERK signaling pathway |
N00005 | Mutation-activated MET to RAS-ERK signaling pathway |
N00006 | Amplified EGFR to RAS-ERK signaling pathway |
N00007 | EML4-ALK fusion kinase to RAS-ERK signaling pathway |
N00008 | RET fusion kinase to RAS-ERK signaling pathway |
N00009 | TRK fusion kinase to RAS-ERK signaling pathway |
N00011 | Mutation-activated FGFR3 to RAS-ERK signaling pathway |
N00014 | Mutation-activated EGFR to RAS-ERK signaling pathway |
N00015 | PDGF-PDGFR-RAS-ERK signaling pathway |
N00016 | PDGF-overexpression to RAS-ERK signaling pathway |
N00018 | Amplified PDGFR to RAS-ERK signaling pathway |
N00019 | FGF-FGFR-RAS-ERK signaling pathway |
N00020 | Amplified FGFR to RAS-ERK signaling pathway |
N00021 | EGF-ERBB2-RAS-ERK signaling pathway |
N00022 | ERBB2-overexpression to RAS-ERK signaling pathway |
N00030 | EGF-EGFR-RAS-PI3K signaling pathway |
N00031 | Duplication or mutation-activated FLT3 to RAS-PI3K signaling pathway |
N00041 | EGFR-overexpression to RAS-ERK signaling pathway |
N00077 | HRAS-overexpression to ERK signaling pathway |
N00078 | Mutation-activated HRAS to ERK signaling pathway |
N00096 | EGF-EGFR-RAS-RASSF1 signaling pathway |
N00097 | Loss of RASSF1 to RAS-RASSF1 signaling pathway |
N00103 | EGF-EGFR-RAS-RalGDS signaling pathway |
N00152 | CXCR-GNB/G-ERK signaling pathway |
N00160 | KSHV K1 to RAS-ERK signaling pathway |
N00215 | KITLG-KIT-RAS-ERK signaling pathway |
N00216 | HGF-MET-RAS-ERK signaling pathway |
N00217 | FLT3LG-FLT3-RAS-ERK signaling pathway |
N00218 | FLT3LG-FLT3-RAS-PI3K signaling pathway |
N00229 | TGFA-EGFR-RAS-ERK signaling pathway |
N00230 | TGFA-overexpression to RAS-ERK signaling pathway |
N00233 | IGF-IGF1R-RAS-ERK signaling pathway |
N00235 | IGF2-overexpression to RAS-ERK signaling pathway |
N00237 | IGF1R-overexpression to RAS-ERK signaling pathway |
N00246 | HGF-overexpression to RAS-ERK signaling pathway |
N00248 | MET-overexpression to RAS-ERK signaling pathway |
N00252 | Amplified ERBB2 to RAS-ERK signaling pathway |
N00259 | Amplified MET to RAS-ERK signaling pathway |
N00276 | EGF-overexpression to RAS-ERK signaling pathway |
N00277 | EREG-EGFR-RAS-ERK signaling pathway |
N00278 | EREG-overexpression to RAS-ERK signaling pathway |
N00279 | AREG-EGFR-RAS-ERK signaling pathway |
N00280 | AREG-overexpression to RAS-ERK signaling pathway |
N00367 | HPV E5 to EGFR-RAS-ERK signaling pathway |
N00386 | HCMV gB to PDGFR-RAS-ERK signaling pathway |
N00513 | Mutation-activated EGFR to RAS-ERK signaling pathway |
N00538 | Ca2+-PYK2-RAS-ERK signaling pathway |
N00540 | HBV HBx to RAS-ERK signaling pathway |
N00541 | HBV HBx to RAS-ERK signaling pathway |
N00542 | EGF-EGFR-RAS-JNK signaling pathway |
N00994 | AGE-RAGE signaling pathway |
N00996 | Mutation-caused aberrant Abeta to AGE-RAGE signaling pathway |
N01062 | Mutation-activated MET to RAS-ERK signaling pathway |
N01064 | Mutation-activated RET to RAS-ERK signaling pathway |
N01343 | ACH-CHRN-RAS-ERK signaling pathway |
N01344 | NNK/NNN to RAS-ERK signaling pathway |
N01351 | E2-ER-RAS-ERK signaling pathway |
N01352 | BPA to RAS-ERK signaling pathway |
N01353 | E2 to RAS-ERK signaling pathway |
N01354 | BPA to RAS-ERK signaling pathway |
N01360 | P4-PR-RAS-ERK signaling pathway |
N01361 | P4/MPA to PR-RAS-ERK signaling pathway |
N01408 | Metals to RAS-ERK signaling pathway |
N01592 | GF-RTK-RAS-ERK signaling pathway |
N01596 | Regulation of GF-RTK-RAS-ERK signaling, RAS ubiquitination by CUL3 complex |
N01597 | Regulation of GF-RTK-RAS-ERK signaling, SPRED and NF1 |
N01600 | Regulation of GF-RTK-RAS-ERK signaling, RasGAP |
N01658 | GF-RTK-RAS-PI3K signaling pathway |
N01874 | NRG-ERBB2/ERBB3 pathway (RAS-ERK signaling) |
|
Disease |
H00040 | Squamous cell carcinoma |
H00523 | Noonan syndrome and related disorders |
H01470 | Giant cell tumor of bone |
H01592 | Medullary thyroid cancer |
H02628 | Schimmelpenning-Feuerstein-Mims syndrome |
H02874 | Congenital melanocytic nevus syndrome |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09130 Environmental Information Processing
09132 Signal transduction
04014 Ras signaling pathway
3265 (HRAS)
04015 Rap1 signaling pathway
3265 (HRAS)
04630 JAK-STAT signaling pathway
3265 (HRAS)
04068 FoxO signaling pathway
3265 (HRAS)
04072 Phospholipase D signaling pathway
3265 (HRAS)
04071 Sphingolipid signaling pathway
3265 (HRAS)
04151 PI3K-Akt signaling pathway
3265 (HRAS)
04150 mTOR signaling pathway
3265 (HRAS)
09140 Cellular Processes
09141 Transport and catabolism
04144 Endocytosis
3265 (HRAS)
04140 Autophagy - animal
3265 (HRAS)
04137 Mitophagy - animal
3265 (HRAS)
09144 Cellular community - eukaryotes
04550 Signaling pathways regulating pluripotency of stem cells
3265 (HRAS)
09150 Organismal Systems
09151 Immune system
04650 Natural killer cell mediated cytotoxicity
3265 (HRAS)
04660 T cell receptor signaling pathway
3265 (HRAS)
04662 B cell receptor signaling pathway
3265 (HRAS)
04664 Fc epsilon RI signaling pathway
3265 (HRAS)
04062 Chemokine signaling pathway
3265 (HRAS)
09152 Endocrine system
04929 GnRH secretion
3265 (HRAS)
04915 Estrogen signaling pathway
3265 (HRAS)
04917 Prolactin signaling pathway
3265 (HRAS)
04921 Oxytocin signaling pathway
3265 (HRAS)
04926 Relaxin signaling pathway
3265 (HRAS)
04935 Growth hormone synthesis, secretion and action
3265 (HRAS)
04919 Thyroid hormone signaling pathway
3265 (HRAS)
09156 Nervous system
04725 Cholinergic synapse
3265 (HRAS)
04726 Serotonergic synapse
3265 (HRAS)
04720 Long-term potentiation
3265 (HRAS)
04730 Long-term depression
3265 (HRAS)
04722 Neurotrophin signaling pathway
3265 (HRAS)
09158 Development and regeneration
04360 Axon guidance
3265 (HRAS)
09149 Aging
04211 Longevity regulating pathway
3265 (HRAS)
04213 Longevity regulating pathway - multiple species
3265 (HRAS)
09159 Environmental adaptation
04714 Thermogenesis
3265 (HRAS)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
3265 (HRAS)
05206 MicroRNAs in cancer
3265 (HRAS)
05205 Proteoglycans in cancer
3265 (HRAS)
05207 Chemical carcinogenesis - receptor activation
3265 (HRAS)
05208 Chemical carcinogenesis - reactive oxygen species
3265 (HRAS)
05203 Viral carcinogenesis
3265 (HRAS)
05230 Central carbon metabolism in cancer
3265 (HRAS)
05231 Choline metabolism in cancer
3265 (HRAS)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
3265 (HRAS)
09162 Cancer: specific types
05210 Colorectal cancer
3265 (HRAS)
05225 Hepatocellular carcinoma
3265 (HRAS)
05226 Gastric cancer
3265 (HRAS)
05214 Glioma
3265 (HRAS)
05216 Thyroid cancer
3265 (HRAS)
05221 Acute myeloid leukemia
3265 (HRAS)
05220 Chronic myeloid leukemia
3265 (HRAS)
05218 Melanoma
3265 (HRAS)
05211 Renal cell carcinoma
3265 (HRAS)
05219 Bladder cancer
3265 (HRAS)
05215 Prostate cancer
3265 (HRAS)
05213 Endometrial cancer
3265 (HRAS)
05224 Breast cancer
3265 (HRAS)
05223 Non-small cell lung cancer
3265 (HRAS)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
3265 (HRAS)
05170 Human immunodeficiency virus 1 infection
3265 (HRAS)
05161 Hepatitis B
3265 (HRAS)
05160 Hepatitis C
3265 (HRAS)
05163 Human cytomegalovirus infection
3265 (HRAS)
05167 Kaposi sarcoma-associated herpesvirus infection
3265 (HRAS)
05165 Human papillomavirus infection
3265 (HRAS)
09164 Neurodegenerative disease
05010 Alzheimer disease
3265 (HRAS)
05022 Pathways of neurodegeneration - multiple diseases
3265 (HRAS)
09165 Substance dependence
05034 Alcoholism
3265 (HRAS)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
3265 (HRAS)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
3265 (HRAS)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
3265 (HRAS)
01522 Endocrine resistance
3265 (HRAS)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:hsa04131]
3265 (HRAS)
09183 Protein families: signaling and cellular processes
04147 Exosome [BR:hsa04147]
3265 (HRAS)
04031 GTP-binding proteins [BR:hsa04031]
3265 (HRAS)
Membrane trafficking [BR:hsa04131]
Exocytosis
Small GTPases and associated proteins
Other small GTPases and associated proteins
3265 (HRAS)
Endocytosis
Macropinocytosis
Ras GTPases
3265 (HRAS)
Exosome [BR:hsa04147]
Exosomal proteins
Exosomal proteins of other body fluids (saliva and urine)
3265 (HRAS)
Exosomal proteins of colorectal cancer cells
3265 (HRAS)
GTP-binding proteins [BR:hsa04031]
Small (monomeric) G-proteins
Ras Family
Ras [OT]
3265 (HRAS)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
LinkDB |
|
Position |
11:complement(532242..535576)
|
AA seq |
189 aa
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDL
AARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQHKLRKLNPPDESGPG
CMSCKCVLS |
NT seq |
570 nt +upstreamnt +downstreamnt
atgacggaatataagctggtggtggtgggcgccggcggtgtgggcaagagtgcgctgacc
atccagctgatccagaaccattttgtggacgaatacgaccccactatagaggattcctac
cggaagcaggtggtcattgatggggagacgtgcctgttggacatcctggataccgccggc
caggaggagtacagcgccatgcgggaccagtacatgcgcaccggggagggcttcctgtgt
gtgtttgccatcaacaacaccaagtcttttgaggacatccaccagtacagggagcagatc
aaacgggtgaaggactcggatgacgtgcccatggtgctggtggggaacaagtgtgacctg
gctgcacgcactgtggaatctcggcaggctcaggacctcgcccgaagctacggcatcccc
tacatcgagacctcggccaagacccggcagggagtggaggatgccttctacacgttggtg
cgtgagatccggcagcacaagctgcggaagctgaaccctcctgatgagagtggccccggc
tgcatgagctgcaagtgtgtgctctcctga |